Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series

Low-grade serous carcinoma represents a minority of serous carcinoma. Although they have better prognosis than high-grade serous carcinoma, they respond poorly to chemotherapy. Thus, it appears necessary to find other treatments such as targeted therapies. Since RAS or RAF mutations occur frequently...

Descripción completa

Detalles Bibliográficos
Autores principales: Niogret, Julie, Derangère, Valentin, Richard, Corentin, Nuttin, Lisa, Ghiringhelli, François, Favier, Laure, Lefevre, Leila Bengrine, Bergeron, Anthony, Arnould, Laurent, Boidot, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948991/
https://www.ncbi.nlm.nih.gov/pubmed/35328764
http://dx.doi.org/10.3390/ijms23063343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948991/
https://www.ncbi.nlm.nih.gov/pubmed/35328764
http://dx.doi.org/10.3390/ijms23063343

Ejemplares similares